Large drop HIV diagnoses in London gay men
By
Dr.Fourkan Ali
Four sexual health
clinics serving large numbers of gay men in London have reported that they
diagnosed far fewer gay men with HIV during 2016 than they
did during 2015. These are preliminary figures and have not been fully
analysed, but many doctors believe that the use of pre-exposure prophylaxis
(PrEP) is part of the explanation for these reductions.
Such
large drops in new diagnoses are unprecedented. 56 Dean Street had 40% fewer
diagnoses overall, the Mortimer Market Centre 50% fewer, Homerton Sexual Health
40% fewer in gay men, and Barts Sexual Health Centre 36% fewer diagnoses in gay
men.
On
their Facebook page, 56 Dean Street summed up the factors which they believe
may have contributed to the fall: “Condoms, PrEP, early diagnosis, immediate
treatment.” They noted that they were testing as many people as the previous
year and that rates of other sexually transmitted infections were as high as
ever. Getting people who have HIV diagnosed and on to treatment as quickly as
possible is probably part of the explanation – but clinics have been working
towards this goal for several years already.
What
appears to be new in 2016 is individuals importing PrEP medication from abroad
and getting support on using PrEP safely. Dr Mags Portman of the Mortimer
Market Centre said: "We made a decision to actively support those buying
PrEP online early in 2016. This approach has been embraced by all
staff from nurses to health advisors to doctors. We ensure that our
patients at higher risk of HIV are fully informed about the use of PrEP and
have access to safe monitoring alongside good sexual health advice and regular
STI screening.”
The
number of men taking PrEP may only be a few hundred or a few thousand, but
these men may be key to slowing the epidemic. “The important thing is whether
awareness and usage of PrEP is reaching the right people,”
commented Dr Alan McOwan of 56 Dean Street. “If the ‘nodal’ gay men who have a
lot of partners and who would have previously been at the centre of a cluster
of infections are now not becoming infected, they are not passing it on to
anyone else.”.
Hepatitis C virus often found in
rectal fluid
Our
understanding of how hepatitis C can be passed on during sex between men
continues to evolve.
It
has generally been thought that sexual transmission is mostly linked to sexual
practices that involve some contact with blood (including tiny traces of blood
you don’t notice). This makes sense as it is well known that hepatitis C is
present in infectious quantities in blood. These sexual practices may include anal
sex (especially when it goes on for a long time) as well as fisting and using
sex toys.
But
last year, American researchers reported that the virus can often
be found in semen. In a group of men who had both HIV
and hepatitis C, one third of the men had detectable hepatitis C in their
semen. It was present in levels that were plausibly high enough to transmit the
virus.
Now
the same group of researchers have reported that
they have also found hepatitis C in the men’s rectal fluid (in
other words, secretions in the rectum). Just under half the group had
detectable levels of hepatitis C in their rectal fluid. Men with higher
hepatitis C viral loads in their blood tended to have higher levels in their
rectal fluid.
This
means that blood is not required for hepatitis C to be passed on. During anal
sex without a condom, hepatitis C can be transmitted. If the insertive partner
(the top) has hepatitis C, it may be present in his semen, so he could pass the
infection on to the other man. Or if the receptive partner (the bottom) has
hepatitis C, it could be present in his rectal fluid, so he could pass the
infection on.
The
researchers say that health organisations need to update the information they
provide on hepatitis C. Educational resources and campaigns need to reflect
what we now know about how hepatitis C is transmitted. In line with this, NAM
has just updated its illustrated leaflet, ‘How hepatitis C is
passed on during sex’.
More
medical conditions in people living with HIV as they get older People living with
HIV are increasingly experiencing a range of medical conditions and
co-morbidities as they get older, according to a large American
study.
Thanks
to effective HIV treatment, more HIV-positive people are surviving to older
ages. But they may be at higher risk of developing a range of health problems.
This may be because of lifestyle factors and the immune system’s response to
HIV, but there is scientific debate about the precise causes.
The
American researchers looked at data on 37,000 people living with HIV, comparing
each individual with up to three HIV-negative people who they were matched
with, based on their age, sex, ethnicity and type of health coverage. Just over
half the participants had commercial health insurance (typically the healthiest
people in the United States, with the best access to healthcare) while the
others were covered by Medicaid (a programme for people on low incomes, who may
have had problems accessing healthcare in the past).
Data
were included from 2003 to 2013. The average age of people living with HIV
increased during this period – as did the number of people with additional
medical conditions.
People
living with HIV had more medical conditions than HIV-negative people. People on
Medicaid generally had more health problems than those with commercial
coverage.
For
example, amongst those with commercial insurance, 7% of HIV-positive people and
4% of HIV-negative people had heart disease. The figures for those covered by
Medicaid were 11% and 8% respectively.
Figures
were also high for kidney disease – amongst those with commercial insurance, 9%
of HIV-positive people, compared with 3% of HIV-negative people. They were also
elevated for osteoporosis (brittle bones) and fractures.
But
rates of some health conditions were no higher in HIV-positive than
HIV-negative people. And these were the most common health conditions – high
blood pressure (31% of HIV-positive people with commercial insurance), raised
cholesterol or triglycerides (31% of HIV-positive people with commercial
insurance), diabetes and other endocrine disorders (21% of HIV-positive people
with commercial insurance). Rates were similar in HIV-negative people.
A separate study,
comparing people with HIV and people with HIV/hepatitis C co-infection, found
that people in the second group were more likely to have kidney disease and
osteoporosis. People who had hepatitis C that had not been brought under
control by treatment had higher rates of diabetes. But it’s unclear whether
these raised rates are due to the impact of hepatitis C or due to lifestyle
factors – for example, people who had hepatitis C were more likely to inject
drugs, drink heavily and smoke.
London-wide HIV
prevention programme to face 10% budget cuts
The
London HIV Prevention Programme (LHPP)’s budget is set to be cut by 10% as part
of wider public health cuts.
The
London Councils’ Leaders’ Committee was asked to endorse the cuts at a meeting
yesterday.
The
London Borough of Lambeth commissioned the LHPP in 2014 on behalf of all local
authorities in the capital to address the high prevalence of HIV. Almost half of
all new HIV diagnoses in 2014 were in London.
The
programme is due to expire in March 2017. Council leaders were asked to approve
it for a further two years, but with a cut in the total funding from borough
councils from £1.2m a year to £1.08m.
The
report said that the cuts were needed because of national cuts to public health
budgets. Councils took over responsibility for public health under the Health
and Social Care Act 2012, but the budget is due to be cut from £3.47bn to just
under £3bn by 2021. Earlier this year, the Health Select Committee called the cuts “a false
economy”.
After
March 2019, there will be no ring-fenced funding for public health because
councils will fund themselves through 100% business rates retention, which
London Councils has previously said could lead to its local authorities losing funding.
The
cuts come despite the programme successfully meeting its goals. A survey found
that almost 70% of respondents who had seen the ‘Do It London’ public awareness
campaign felt it had positively influenced their sexual behaviour and attitude
towards HIV testing. It has also been linked to a drop in the overall rate of
new HIV diagnosis in capital and in the percentage of HIV infections diagnosed
late.
The
LGA has used the LHPP as a case study of good practice in local authority
sexual health commissioning. London mayor Sadiq Khan has described it as “a
genuinely collaborative response to a London-wide issue” which has his “full
support” to continue beyond 2017.
London
Councils said it was confident that the savings could be achieved because
Lambeth council has already been able to make efficiency savings in the
programme. For example, it secured a 36% increase in the number of condoms
being distributed for £1.2m less than the previous NHS campaign.
Yusef
Azad, director of strategy at the National AIDS Trust, said: “NAT welcomes the
commitment to continue the London HIV prevention programme for a further two
years; it is an innovative and collaborative approach for the capital. We
are disappointed to see a reduction in financial contributions – at this time
we need more, not less, investment in prevention. We would also emphasise
that the LHPP does not replace the need for local authorities to understand and
meet the HIV prevention needs of their residents, through their public health
responsibilities.”
The writer Teacher & Columnist
8801611579267
dr.fourkanali@gmail.com
0 comments:
Post a Comment